$CHCT

Community Healthcare Trust Announces Results for the Three Months Ended June 30, 2026

Community Healthcare Trust Inc. (NYSE: CHCT) reported net income of about $2.4 million, or $0.06 per diluted share, for the three months ended June 30, 2026. FFO and AFFO were $0.48 and $0.56 per diluted share. The board cut the quarterly dividend to $0.33 per share, payable Aug. 31, 2026. CHCT also outlined occupancy, capital recycling, and acquisition pipeline plans.

Original reporting
Published Aug 4, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 9:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CHCT
Neutral
medium confidence
Mentioned
$CHCT
Relevance
7/10
alphai data visualization · based on prnewswire.com
Decision brief

The 30-second read

$CHCTNeutralMed
01

Why it matters

The key tradable elements are the quarterly dividend reset, the stated AFFO payout ratio target, and the timing-dependent acquisition pipeline under definitive agreements, plus expanded FAD/Supplemental disclosure that may change how investors model distributable cash flow.

02

Market read

Investors get a fresh dividend level, updated cash-flow framing (FAD), and a quantified capital recycling and acquisition plan, but must weigh closing/timing uncertainty.

03

What to watch

Tenant business-sale progress (LOI to definitive purchase documents) could affect lease terms and occupancy trajectory, which is central to the 92% occupancy target.

Relevance 7/10Novelty 7/10Timing: after-hours today, with dividend payable Aug. 31 and record date Aug. 19

Background

Community Healthcare Trust is a healthcare-focused REIT owning outpatient healthcare service properties across the US; this release covers Q2 2026 results and capital allocation updates.

Company-level read

Ticker impact

$CHCTNeutralMedium confidence
Context

CHCT reported Q2 2026 net income and FFO/AFFO per share, declared a $0.33 quarterly dividend, and outlined occupancy and acquisition targets for 18 to 24 months.

Expected impact

Likely modest volatility around dividend and guidance-style targets, with upside/downside driven by perceived probability and timing of the under-contract acquisitions and tenant sale/lease renewal outcomes.

Evidence & confidence

The release provides concrete quarterly metrics and a new dividend level, but it does not give explicit forward guidance for earnings/FFO beyond strategic targets and closing timing uncertainty for acquisitions.

Market effects

REIT investors may reprice healthcare REIT dividend sustainability and capital recycling assumptions based on CHCT’s rightsize plan and FAD disclosure expansion.

Limited, as the portfolio is spread across 36 states and the news is company-specific.

Low, as this is a US healthcare REIT earnings and capital allocation update.

Counterpoint

The dividend reduction could signal weaker cash flow durability than management implies, and the acquisition pipeline may slip given the repeated closing uncertainty language.

Key entities

  • Community Healthcare Trust Incorporated

    NYSE-listed healthcare REIT reporting Q2 2026 results, declaring a reduced quarterly dividend, and detailing strategic capital allocation and pending acquisitions.

  • Geriatric behavioral hospital operator (tenant)

    Tenant in six CHCT properties that paid $0.4 million in Q2 rent and is progressing a sale process that includes new leases on the hospitals.

Related articles

$CHCTMed

Community Healthcare Trust Inc (CHCT): Results of Operations and Financial Condition

Community Healthcare Trust Inc (CHCT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 News Release Community Healthcare Trust Announces Results for the Three Months Ended June 30, 2026 FRANKLIN, Tenn., August 4, 2026 / PRNewswire / -- Community Healthcare Trust Incorporated (NYSE: CHCT ) (the "Company") today announced results for the three months end

$WDAYMedAI 8/10

Workday earnings analysis: questions answered and next catalysts

Workday (WDAY) reported Q2 FY2027 earnings beating revenue ($2.65B) and EPS ($2.75) estimates, but Q3 cRPO guidance (11-12%) missed expectations. AI products reached $600M ARR, up 200% YoY, while margins expanded to 31.1%. The company completed a $5B share buyback and authorized a new $4B program. Management did not address acquisition rumors. Next catalysts include Q3 earnings, potential Silver Lake deal, and AI monetization progress.

$RBRKHighAI 8/10

Rubrik earnings analysis: questions answered and next catalysts

Rubrik (RBRK) reported Q2 FY2027 earnings with EPS of $0.20 (vs. $0.04 expected) and revenue of $427.3M (vs. $396.3M forecast), but shares fell 10.4% due to slower-than-expected cloud ARR growth. Subscription ARR grew 33% YoY, while cloud net new ARR grew 20%. Management highlighted Identity Resilience as a growth driver and confirmed no ARR contribution from the Strata acquisition. Free cash flow rose to $65.7M, and profitability targets were reaffirmed. Analysts remain bullish, with a mean pri

$SMedAI 8/10

SentinelOne earnings analysis: questions answered and next catalysts

SentinelOne reported Q2 FY2027 revenue of $292M, beating estimates, with a record 10% operating margin. However, Q3 EPS guidance of $0.08–$0.09 missed consensus. The stock dropped 6.7%. Analysts are split, with some highlighting strong ARR growth and others citing valuation concerns. Next catalysts include Q3 earnings and AI security monetization.

$MRVLHighAI 9/10

Marvell Technology earnings analysis: questions answered and next catalysts

Marvell Technology (MRVL) reported Q2 FY2027 earnings, beating EPS and revenue estimates. Despite this, shares fell 8.2% due to high expectations. Data center revenue grew 27% YoY, driven by AI and cloud computing. The company secured a $120B deal with Google and maintained strong margins. Guidance for Q3 was above consensus, but analysts noted the stock's recent rally. Next catalysts include Q3 earnings, optical product ramps, and acquisitions. MRVL trades at 29x CY2028 earnings, with a PEG rat

$CRMHighAI 9/10

Cramer Says the Bears Spent Months Lying About Salesforce and Nvidia. One Earnings Report Just Ended It.

Salesforce (CRM) rose 23% after reporting strong seat growth and low attrition, with Agentforce ARR up 240% to $1.5B. NVIDIA (NVDA) guided Q3 revenue to $108B, exceeding estimates. Jim Cramer argued bearish theses on both companies were refuted by earnings. Salesforce reported $11.35B revenue and raised FY27 guidance. NVIDIA's Q2 revenue was $96.22B, up 105.85% YoY, with Q3 guidance at $108B.